---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-23-001101"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:10:48.448171+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NYSE American warns China Pharma of delisting; avg price below $0.20, cure by March 2024

## Summary
- On Sep 27, 2023, NYSE American notified CPHI of noncompliance: 30-day avg stock price below $0.20.
- Company must effect a reverse stock split or demonstrate sustained price improvement by Mar 27, 2024.
- Continues to address prior stockholders' equity noncompliance from June 2022.
- Listing remains on NYSE American during cure period; business operations unaffected.

## SEC filing metadata
- accession: 0001013762-23-001101
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000101376223001101/0001013762-23-001101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000101376223001101/ea186256-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-23-001101
- JSON: https://secwatch.observer/filing/0001013762-23-001101.json
- Plain text: https://secwatch.observer/filing/0001013762-23-001101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.